GPT and Cirrhosis: Among an international cohort of 299 biopsy-proven NAFLD patients [only included patients with cirrhosis], the ABIDE model [consisting of AST/ALT ratio, total bilirubin, INR, history of type 2 diabetes mellitus, and presence of esophageal varices] was tested using a derivation and validation cohort [14].